Skip to main content

Association of Simian Virus 40 with Rodent and Human Mesotheliomas

  • Chapter
DNA Tumor Viruses

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

Abstract

Simian virus 40 (SV40) is an oncogenic papovavirus capable of inducing tumors in hamsters and of transforming cells from many species in tissue culture.(1) In the past, although useful for basic studies, the SV40-induced hamster tumor model was considered to have only limited relevance in the elucidation of mechanisms for human cancer development. Recently, however, the discovery of relationships between SV40 proteins and human tumor suppressor gene products suggested that DNA tumor viruses could possibly illuminate molecular mechanisms of human carcinogenesis.(2) Moreover, the very recent finding of SV40-like sequences in human tumors(3,4) underscores the direct relevance of SV40 research to human cancer. The SV40 proteins associated with in vivo oncogenesis and in vitro cell transformation are encoded by the early region of the virus; these proteins are known as the T (tumor) antigens because animals bearing tumors induced by SV40 have antibodies against these viral proteins. Two SV40 tumor antigens are detected in infected or transformed cells, “large T antigen” (Tag) and “small t antigen” (tag), and these two proteins are produced from a single viral gene by differential splicing of an RNA transcript.(1,2) Unlike the oncogenes of the retroviruses, the T antigen oncogenes of SV40 do not have a homologous cellular protooncogene.(5)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Topp, W. C., Lane, D., and Pollack, R., 1981, Transformation by SV40 and polyoma virus, in: DNA Tumor Viruses, part 2, revised (J. Tooze, ed.), Cold Spring Harbor Press, New York, pp. 205–296.

    Google Scholar 

  2. Fanning, E., and Knippers, R., 1992, Structure and function of simian virus 40 large tumor antigen, Annu. Rev. Biochem. 61:55–85.

    Article  PubMed  CAS  Google Scholar 

  3. Bergsagel, D. J., Finegold, M. J., Butel, J. S., Kupsky, W. J., and Garcea, R., 1992, DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood, N. Engl. J. Med. 36:988–993.

    Article  Google Scholar 

  4. Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M. R., Di Muzio, M., Mew, D.J. Y., Levine, A. S., and Procopio, A., 1994, Simian virus 40-like DNA sequences in human pleural mesothelioma, Oncogene 9:1781–1790.

    PubMed  CAS  Google Scholar 

  5. Carbone, M., and Levine, A. S., 1990, Oncogenes, antioncogenes and the regulation of cell growth, Trends Endocrinol. Metab. 1:248–253.

    Article  PubMed  CAS  Google Scholar 

  6. Butel, J. S., 1986, SV40 large T antigen: Dual oncogene, Cancer Surv. 5:343–365.

    PubMed  CAS  Google Scholar 

  7. Geissler, E., and Theile, M., 1983, Virus-induced gene mutations of eukaryotic cells. Hum. Genet. 63:1–12.

    Article  PubMed  CAS  Google Scholar 

  8. Geissler, E., 1990, SV40 and human brain tumors, Prog. Med. Virol. 37:211–222.

    PubMed  CAS  Google Scholar 

  9. Tiemann, F., and Deppert, W., 1994, Immortalization of Balb/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40-transformation-efficiency, Oncogene 9:1990–1915.

    Google Scholar 

  10. Claudio, P. P., Howard, C. M., Baldi, A., De Luca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, N., Calabretta, B., and Giordano, A., 1994, pl30/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107, Cancer Res. 54:5556–5560.

    PubMed  CAS  Google Scholar 

  11. Avantaggiati, M. L., Carbone, M., Graessmann, A., Howard, B., and Levine, A. S., The SV40 large T antigen and adenovirus Ela interact with different isoforms of the transcriptional coactivator p300, EMBO J., in press.

    Google Scholar 

  12. Porcu, P., Ferber, A., Pietrzkowski, Z., Roberts, C. T., Adamo, M., LeRoith, D., and Baserga, R., 1992, The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor 1 with its receptor, Mol. Cell Biol. 12:5069–5077.

    PubMed  CAS  Google Scholar 

  13. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstradiatis, A., and Baserga, R., 1993, Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor, Proc. Natl Acad. Sci. USA 90:11217–11221.

    Article  PubMed  CAS  Google Scholar 

  14. Valentinis, B., Porcu, P., Quinn, K., and Baserga, R., 1994, The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen, Oncogene 9:825–831.

    PubMed  CAS  Google Scholar 

  15. Scheidtmann, K. H., Mumby, M. C., Rundell, K., and Walter, G., 1991, Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: Inhibition by small-t antigen, Mol. Cell. Biol. 11:1996–2003.

    PubMed  CAS  Google Scholar 

  16. Carbone, M., Hauser, J., Carty, M. C., Rundell, K., Dixon, K., and Levine, A. S., 1992, Simian virus 40 (SV40) small t antigen inhibits SV40 DNA replication in vitro. J. Virol 66:1804–1808.

    PubMed  CAS  Google Scholar 

  17. Sontag, E., Fedorov, S., Kmibayashi, C., Robbins, D., and Mumby, M., 1993, The interaction of the SV40 small t tumor antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation, Cell 75:887–897.

    Article  PubMed  CAS  Google Scholar 

  18. Cicala, C., Avantaggiati, M. L., Graessmann, A., Rundell, K., Levine, A. S., and Carbone, M., 1994, Simian virus 40 small t antigen stimulates viral DNA replication in permissive monkey cells, J. Virol 68:3138–3144.

    PubMed  CAS  Google Scholar 

  19. Lewis, A. M., Jr., and Martin, R. G., 1979, Oncogenicity of simian virus 40 deletion mutants that induce altered 17-kilodalton t-proteins, Proc. Natl Acad. Sci. USA 76:4299–4302.

    Article  PubMed  CAS  Google Scholar 

  20. Gerber, P., and Kirschstein, R. L., 1962, SV40-induced ependymomas in newborn hamsters, Virology 18:582–588.

    Article  PubMed  CAS  Google Scholar 

  21. Allison, A. C., Chesterman, F. C., and Baron, S., 1967, Induction of tumors in adult hamsters with simian virus 40, J. Natl Cancer Inst. 38:567–577.

    PubMed  CAS  Google Scholar 

  22. Diamandopoulous, G. T., 1972, Leukemia, lymphoma and osteosarcoma induced in the Syrian golden hamster by simian virus 40, Science 176:73–75.

    Article  Google Scholar 

  23. Cicala, C., Pompetti, F., and Carbone, M., 1993, SV40 induces mesotheliomas in hamsters, Am. J. Pathol 142:1524–1533.

    PubMed  CAS  Google Scholar 

  24. Eddy, B. E., Simian virus 40: An oncogenic virus, 1964, Prog. Exp. Tumor Res. 4:1–26.

    Google Scholar 

  25. Lipotich, G., Moyer, M. P., and Moyer, R. C., 1982, Rescue of SV40 following transfection of TC7 cells with cellular DNAs containing complete and partial SV40 genomes, Mol Gen. Genet. 186:78–81.

    Article  PubMed  CAS  Google Scholar 

  26. Carbone, M., Pompetti, F., Cicala, C., Nguyen, P., Dixon, K., and Levine, A. S., 1991, The role of small t antigen in SV40 oncogenesis, in: Molecular Basis of Human Cancer (C. Nicolini, ed.), Plenum Press, New York, pp. 191–206.

    Google Scholar 

  27. Dixon, K., Ryder, B. J., and Burche-Jaffe, E., 1982, Enhanced metastasis of tumors induced by a SV40 small t deletion mutant, 1982, Nature 296:672–675.

    Article  PubMed  CAS  Google Scholar 

  28. Carbone, M., Lewis, A. M., Jr., Matthews, B. J., Levine, A. S., and Dixon, K., 1989, Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas, Cancer Res. 49:1565–1571.

    PubMed  CAS  Google Scholar 

  29. Carbone, M., Kajiwara, E., Patch, C. T., Lewis, A. M., Levine, A. S., and Dixon, K., 1989, Biochemical properties of media conditioned by simian virus 40-induced hamster tumor cells: Correlation with distinct cell phenotypes but not with oncogenicity, Cancer Res. 49:6809–6812.

    PubMed  CAS  Google Scholar 

  30. Cicala, C., Pompetti, F., Nguyen, P., Dixon, K., Levine, A. S., and Carbone, M., 1992, SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B-lymphocytes in vivo, Virology 190:475–479.

    Article  CAS  Google Scholar 

  31. Sweet, B. H., and Hilleman, R. M., 1960, The vacuolating virus SV40, Proc. Soc. Exp. Biol. Med. 105:420–427.

    Article  PubMed  CAS  Google Scholar 

  32. Eddy, B. E., 1962, Identification of the oncogenic substance in rhesus monkey kidney cell cultures as SV40, Virology 17:65–75.

    Article  PubMed  CAS  Google Scholar 

  33. Lewis, A. M., Jr., 1973, Experience with SV40 and adenovirus-SV40 hybrids, in: Biohazards in Biological Research (A. Hellman, M. Oxman, and R. Pollack, eds.), Cold Spring Harbor Laboratory Press, New York, pp. 96–113.

    Google Scholar 

  34. Shah, K. V., and Nathanson, N., 1976, Human exposure to SV40: Review and comment, Am. J. Epidemiol. 103:1–12.

    PubMed  CAS  Google Scholar 

  35. Shah, K. V., Goverdhan, M. K., and Ozer, H. L., 1970, Neutralizing antibodies to SV40 in human sera from south India: Search for additional hosts of SV40, Am. J. Epidemiol. 93:291–297.

    Google Scholar 

  36. Shah, K. V., McCrumb, F. R., Jr., Daniel, R. W., and Ozer, H. L., 1972, Serologic evidence for a SV40-like infection in man. J. Natl. Cancer Inst. 48:557–561.

    PubMed  CAS  Google Scholar 

  37. Horvath, L. B., 1965, Incidence of SV40 virus neutralizing antibodies in sera of laboratory workers, 1965, Acta Microbiolol. Acad. Sci. Hung. 12:201–211.

    CAS  Google Scholar 

  38. Gerber, P., 1967, Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccine, Proc. Soc. Exp. Biol. Med. 125:1284–1287.

    Article  PubMed  CAS  Google Scholar 

  39. Melnick, J. L., and Stinebaugh, S., 1962, Excretion of vacuolating SV40 virus (papova virus group) after ingestion as a containment of oral poliovaccine, Proc. Soc. Exp. Biol. Med. 109:965–968.

    Article  PubMed  CAS  Google Scholar 

  40. Morris, J. A. Johnson, K. M., Aulisio, G. C., Chanock, R. M., and Knight, V., 1961, Clinical and sérologie responses in volunteers given vacuolating virus (SV40) by respiratory route, Proc. Soc. Exp. Biol. Med. 108:56–64.

    Article  PubMed  CAS  Google Scholar 

  41. Shein, H. M., and Enders, J. F., 1962, Transformation induced by simian virus 40 in human renal cell cultures. Morphology and growth characteristics, Proc. Natl. Acad. Sci. USA 48:1164–1169.

    Article  PubMed  CAS  Google Scholar 

  42. Koprowski, H., Ponten, J. A., Jensen, E., Ravdin, R. G., Moorhead, P., and Saksela, E., 1962, Transformation of cultures of human tissue infected with SV40, J. Cell. Comp. Physiol. 59:281–292.

    Article  Google Scholar 

  43. Rabson, A. S., Malmgren, R. A., O’Conor, G. T., and Kirschtein, R. L., 1962, Simian vacuolating virus (SV40) infection in cell cultures derived from adult human thyroid tissue, J. Natl. Cancer Inst. 29:1123–1145.

    PubMed  CAS  Google Scholar 

  44. Jensen, F., Koprowski, H., Pagano, J. S., Ponten, J., and Ravdin, R. G., 1964, Autologous and homologous implantation of human cells transformed in vitro by SV40, J. Natl. Cancer Inst. 32:917–925.

    Google Scholar 

  45. Fraumeni, J., Ederer, F., and Miller, R. W., 1963, An evaluation of the carcinogenicity of SV40 in man, J.A.M.A. 185:713–718.

    Article  PubMed  Google Scholar 

  46. Mortimer, E. A., Lepow, M. L., Gold, E., Robbins, F. C., Burton, G. J., and Fraumeni, J. F., 1981, Long-term follow up of persons inadvertently inoculated with SV40 as neonates, N. Engl.J. Med. 305:1517–1518.

    Article  PubMed  Google Scholar 

  47. Weiner, L. P., Herndon, R. M., Narayan, O., Johnson, R. T., Shah, K., Rubinestein, L.J., Preziosi, T.J., and Conley, F. K., 1972, Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy, N. Engt. J. Med. 286:385–390.

    Article  CAS  Google Scholar 

  48. Soriano, F., Shelburne, C. E., and Gokcen, M., 1974, Simian virus 40 in a human cancer, Nature 249:421–424.

    Article  PubMed  CAS  Google Scholar 

  49. Krieg, P., Amtmann, E. Jonas, D., Fisher, H., Zang, K., and Sauer, G., 3981, Episomal simian virus 40 in human brain tumors, Proc. Natl. Acad. Sci. USA 78:6446–6450.

    Article  Google Scholar 

  50. Walsh J. W., Zimmer, S. G., and Perdue, M. L., 1982, Role of viruses in the induction of primary intracranial tumors, Neurosurgery 10:643–662.

    Article  PubMed  CAS  Google Scholar 

  51. Lednicky, J., Garcea, R. L., Bergsagel, DJ., and Butel, J., Natural simian virus 40 in human choroid plexus tumors and ependymomas, Virology, in press.

    Google Scholar 

  52. Henderson, D. W., Shilkin, K. B., Whitaker, D., Attwood, H. D., Constance, T.J., Steele, R. H., and Leppard, P. J., 1992, The pathology of malignant mesothelioma, including immunohistology and ultrastructure, in Malignant Mesothelioma (D. W. Henderson, K. B. Shilkin, S. P. Le Langlois, and D. Whitaker, eds.), The Cancer Series, Hemisphere Press, New York, pp. 69–139.

    Google Scholar 

  53. Pass, H. I., 1994, Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma, Chest Surg. Clin. North Am. 4:497–515.

    CAS  Google Scholar 

  54. Hammar, S. P., 1994, Pleural diseases, in: Pulmonary Pathology, 2d ed. (D. H. Dail and S. P. Hammar, eds.), Springer Verlag, Berlin, pp. 1463–1579.

    Chapter  Google Scholar 

  55. Vogelzang, N.J., Weissman, L. B., Herndon, J. E., Antman, K. H., Cooper, R. M., Corson, J. M., and Green, M. R., 1994, Trimetrexate in malignant mesothelioma: A cancer and leukemia group B phase study, J. Clin. Oncol. 12:1436–1442.

    PubMed  CAS  Google Scholar 

  56. Antman, K. H., Pass, H. I., DeLaney, T., and Recht, A., 1993, Benign and malignant mesothelioma, in: Cancer: Pnnciples and Practice of Oncology, 4th ed. (V. T. De Vita, S. Hellman, and S. A. Rosenberg, eds.), J. B. Lippincott, Philadelphia, pp. 1489–1508.

    Google Scholar 

  57. Mew, D., and Pass, H. I., 1993, Malignant mesotheliomas: A clinical challenge, Contemp. Oncol. 3:50–67.

    Google Scholar 

  58. Pass, H. I., and Pogrebniak, H. W., Malignant pleural mesothelioma, 1993, Curr. Probl. Surg. 30:921–1020.

    Article  PubMed  CAS  Google Scholar 

  59. Fisher, W., 1931, Die Gewachse der Lunge und des Brustfells, in: Handbuch der speziellen pathologischen Anatomie und Hisotlogie. Vol. III/3 (F. Henke and O. Lubarsch, eds.), Springer Verlag, Berlin, pp. 509–539.

    Google Scholar 

  60. Mark, E. J., and Yokoi, T., 1991, Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure, in: The Third Wave of Asbestos Disease: Exposure of Asbestos in Place, Ann. N.Y. Acad. Sci. 643:196–204.

    Article  PubMed  CAS  Google Scholar 

  61. Wagner, J. C., Sleggs, C. A., and Marchand, P. E., 1960, Diffuse pleural mesothelioma and asbestos exposure in the Northwestern Cape Province, Br.J. Ind. Med. 17:260–271.

    PubMed  CAS  Google Scholar 

  62. Selikoff, I. J., Hammond, E. C., and Seidman, H., 1980, Latency of asbestos disease among insulation workers in the United States and Canada, Cancer 46:2736–2740.

    Article  PubMed  CAS  Google Scholar 

  63. Weitzman, S. A., and Graceffa, P., 1984, Asbestos catalyzed hydroxyl and Superoxide radical generation from hydrogen peroxide, Arch. Biochem. Biophys. 228:373–376.

    Article  PubMed  CAS  Google Scholar 

  64. Jaurand, M. C., Fleury, J., Monchaux, G., Nebut, M., and Bignon, J., 1987, Pleural carcinogenic potency of mineral fibers (asbestos attapulgite) and their toxicity on cultured cells, J. Natl. Cancer Inst. 79:797–804.

    PubMed  CAS  Google Scholar 

  65. Weissman, L. B., and Antman, K. H., 1989, Incidence, presentation and promising new treatments for malignant mesothelioma, Oncology 3:67–72.

    Google Scholar 

  66. Mossman, B. T., Bignon, J., Corn, M., Seaton, A., and Gee, J. B. L., Asbestos: Scientific developments and implications for public policy, 1990, Science 247:294-301.

    Google Scholar 

  67. Roggli, V. L., Sanfilippo, F., and Shelburne, J., 1992, Mesothelioma, in: Pathology of Asbestos and Associated Diseases (V. L. Roggli, S. D. Greenberg, and P. C. Pratt, eds.), Little, Brown, Boston, pp. 383–391.

    Google Scholar 

  68. Muscat, J. E., and Wynder, E. L., 1991, Cigarette smoking asbestos exposure and malignant mesothelioma, Cancer Res. 51:2263–2267.

    PubMed  CAS  Google Scholar 

  69. Churg, A., 1993, Asbestos, asbestosis and lung cancer, Mod. Pathol. 6:509–511.

    PubMed  CAS  Google Scholar 

  70. Cooper, S. P., Fraire, A. E., Buffler, P. A., Greenberg, S. D., and Lanston, C., 1989, Epidemiologic aspects of childhood mesothelioma, Pathol. Immunopathol. Res. 8:276–286.

    Article  PubMed  CAS  Google Scholar 

  71. Nishioka, H., Furusho, K., Yasunaga, T., Tanaka, K., Yamanouchi, A., Yokota, T., Ishihara, T., and Nakashima, Y, 1988, Congenital malignant mesothelioma: A case report and electron-microscopic study, Eur.J. Pediatr. 147:428–430.

    Article  PubMed  CAS  Google Scholar 

  72. Peterson, J. T., Greenberg, S. D., and Bufler, P. A., Non-asbestos related malignant mesothelioma, 1984, Cancer 54:951–960.

    Article  PubMed  Google Scholar 

  73. Ke, Y., Reddel, R. R., Gerwin, B. I., Reddel, H. K., Somers, A. N. A., McMenamin, M. G., La Veck, M. A., Stahel, R. A., Lechner, J. F., and Harris, C. C., 1989, Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma, Am. J. Pathol. 134:979–991.

    PubMed  CAS  Google Scholar 

  74. Reddel, R. R., Malan-Shibley, L., Gerwin, B. I., Metcalf, R. A., and Harris, C. C., 1989, Tumorigenicity of human mesothelial cell line transfected with EJ-rasoncogene, J. Natl. Cancer Inst. 81:945–948.

    Article  PubMed  CAS  Google Scholar 

  75. Appel, J. D., Fasy, T. M., Kohtz, D. S., and Johnson, E. M., 1988, Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA, Proc. Natl. Acad. Sci. USA 85:7670–7674.

    Article  PubMed  CAS  Google Scholar 

  76. Dubes, G. R., 1993, Asbestos mediates viral DNA transformation of mouse cells to produce multilayered foci. Proc. Am. Assoc. Cancer Res. 34:185.

    Google Scholar 

  77. Todaro, G. J., and Martin, G. M., 1967, Increased susceptibility of Down’s syndrome fibroblasts to transformation by SV40, Proc. Soc. Exp. Biol. Med. 124:232–1237.

    Google Scholar 

  78. Lewis, A. M., Jr., and Cook, J. L., 1985, A new role for DNA virus early proteins in viral carcinogenesis, Science 227:15–20.

    Article  PubMed  CAS  Google Scholar 

  79. Carbone, M., Rizzo, P., Giuliano, M. T., Procopio, A., Gephardt, M., Hansen, M., Malkin, D., Pompetti, F., Bushart, G., Levine, A. S., Pass, H. I., and Garcea, R., 1995, Incidence of SV40-like sequences in human tumors. Proc. Am. Assoc. Cancer Res. 36:201.

    Google Scholar 

  80. Carbone, M., Rizzo, P., Procopio, A., Mew, D. J. Y., Giuliano, M. T., Steinberg, S. M., Levine, A. S., Grimly, P., and Pass, H. I., 1995, SV40 large T antigen and p53 in human pleural meso-thelioma, J. Cell. Biochem. 19A(suppl.):321.

    Google Scholar 

  81. Metcalf, R., Welsh, J., Bennet, W., Seddon, M., Lehman, T., Pelin, K., Limainmaa, K., Tammilehto, L., Mattson, K., Gerwin, B., and Harris, C. C., 1992, p53 and Kirsten-ras mutations in human mesothelioma cell lines, Cancer Res. 52:2610–2615.

    PubMed  CAS  Google Scholar 

  82. Greenblatt, M. S., Bennett, W. P., and Harris, C. C., 1994, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis, Cancer Res. 54:4855–4878.

    PubMed  CAS  Google Scholar 

  83. Loewe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E., 1993, p53 dependent apoptosis modulates the cytotoxicity of anticancer agents, Cell 74:957–967.

    Article  Google Scholar 

  84. Bright, R. K., Shearer, M. H., and Kennedy, R. C., 1994, Immunization of BALB/c mice with recombinant SV40 large T tumor antigen induces antibody-dependent cell-mediated citotoxicity against simian virus 40-transformed cells, J. Immunol. 153:2064–2072.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Carbone, M., Rizzo, P., Pass, H.I. (1995). Association of Simian Virus 40 with Rodent and Human Mesotheliomas. In: Barbanti-Brodano, G., Bendinelli, M., Friedman, H. (eds) DNA Tumor Viruses. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1100-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1100-1_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1102-5

  • Online ISBN: 978-1-4899-1100-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics